Volume 147, Issue 1, Pages (July 2014)

Slides:

Advertisements

Similar presentations

Value in Health Regional Issues

Advertisements

Volume 136, Issue 2, Pages (February 2009)

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection Yi–Cheng Chen, I.–Shyan Sheen,

Volume 148, Issue 7, Pages e3 (June 2015)

Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

Level of α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C–Related Hepatocellular Carcinoma Gia L. Tyson, Zhigang Duan, Jennifer R. Kramer,

Les Lang Gastroenterology Volume 133, Issue 1, (July 2007)

Volume 138, Issue 5, Pages e1 (May 2010)

Presentation, Treatment, and Clinical Outcomes of Patients With Hepatocellular Carcinoma, With and Without Human Immunodeficiency Virus Infection Adam.

Covering the Cover Gastroenterology

Volume 142, Issue 5, Pages e3 (May 2012)

Volume 136, Issue 1, Pages (January 2009)

Volume 132, Issue 3, Pages (March 2007)

Volume 153, Issue 4, Pages (October 2017)

Value in Health Regional Issues

Outcomes Among Living Liver Donors

A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus Amit G. Singal, Michael.

Increased Mortality Among Persons Infected With Hepatitis C Virus

Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective.

Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection Sahil Mittal, Jennifer R. Kramer, Ronald Omino,

Volume 137, Issue 5, Pages (November 2009)

Covering the Cover Gastroenterology

Volume 135, Issue 4, Pages (October 2008)

Volume 133, Issue 5, Pages (November 2007)

Volume 150, Issue 4, Pages (April 2016)

Volume 154, Issue 4, Pages (March 2018)

Volume 133, Issue 5, Pages (November 2007)

Volume 155, Issue 5, Pages e2 (November 2018)

Jean-Michel Pawlotsky Gastroenterology

Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H

Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay? Brian J. McMahon, MD, Brenna C. Simons, PhD Clinical.

Volume 152, Issue 5, Pages e1 (April 2017)

Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill

Volume 145, Issue 1, Pages (July 2013)

Volume 142, Issue 6, Pages e3 (May 2012)

Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States Ju Dong Yang, Joseph.

George N. Ioannou, Meaghan F. Splan, Noel S. Weiss, George B

Hashem El–Serag, Anna S.F. Lok, David L. Thomas Gastroenterology

Eric S. Orman, Marwan Ghabril, Naga Chalasani

Constance E. Ruhl, James E. Everhart Gastroenterology

Volume 133, Issue 2, Pages (August 2007)

Volume 150, Issue 7, Pages (June 2016)

Volume 136, Issue 2, Pages (February 2009)

Volume 133, Issue 6, Pages (December 2007)

Hepatitis B Virus Load in Serum Does Not Reflect Histologic Activity in Patients With Decompensated Cirrhosis Jin Dong Kim, Jong Young Choi, Si Hyun.

Volume 148, Issue 7, Pages (June 2015)

Volume 148, Issue 3, Pages (March 2015)

Covering the Cover Gastroenterology

Jeremy P. Dwyer, Patrick Hosking, John Lubel Gastroenterology

Issue Highlights Clinical Gastroenterology and Hepatology

Decreasing Mortality Among Patients Hospitalized With Cirrhosis in the United States From 2002 Through 2010 Monica L. Schmidt, A. Sidney Barritt, Eric.

Jikyoung Lee, Jong Jin Hyun, Hong Sik Lee Gastroenterology

Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C Gowtham A. Rao, Prashant K. Pandya Gastroenterology

The Dawning of a New Editorial Board for Gastroenterology

Ju Dong Yang, W. Ray Kim, Ritika Coelho, Teresa A. Mettler, Joanne T

Donor Race Does Not Predict Graft Failure After Liver Transplantation

Alessio Aghemo, Maria Francesca Donato Gastroenterology

Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States Zobair M. Younossi, Maria Stepanova

Volume 126, Issue 4, Pages (April 2004)

Volume 156, Issue 3, Pages (February 2019)

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection Yi–Cheng Chen, I.–Shyan Sheen,

Volume 139, Issue 6, Pages e1 (December 2010)

Volume 156, Issue 5, Pages e3 (April 2019)

Volume 138, Issue 6, Pages (May 2010)

Volume 152, Issue 5, Pages e1 (April 2017)

Covering the Cover Gastroenterology

Volume 130, Issue 3, Pages (March 2006)

Controversies in Liver Transplantation for Hepatitis C

Volume 156, Issue 4, Pages (March 2019)

Presentation transcript:

Volume 147, Issue 1, Pages 152-161 (July 2014) Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine Young–Suk Lim, Seungbong Han, Nae–Yun Heo, Ju Hyun Shim, Han Chu Lee, Dong Jin Suh Gastroenterology Volume 147, Issue 1, Pages 152-161 (July 2014) DOI: 10.1053/j.gastro.2014.02.033 Copyright © 2014 AGA Institute Terms and Conditions

Figure 1 Patient flow diagram. HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; HDV, hepatitis delta virus; HIV, human immunodeficiency virus. Gastroenterology 2014 147, 152-161DOI: (10.1053/j.gastro.2014.02.033) Copyright © 2014 AGA Institute Terms and Conditions

Figure 2 Cumulative incidence of death or transplantation and HCC in the overall propensity score-matched cohort. Propensity score matching of the entire cohort created 1792 matched pairs of patients. (A) Cumulative incidence of death or transplantation. (B) Cumulative incidence of HCC. Gastroenterology 2014 147, 152-161DOI: (10.1053/j.gastro.2014.02.033) Copyright © 2014 AGA Institute Terms and Conditions

Figure 3 Cumulative incidence of death or transplantation and HCC in propensity score-matched cohorts with and without cirrhosis. Propensity score matching created 860 and 878 matched pairs of patients with and without cirrhosis, respectively. (A) Cumulative incidence of death or transplantation in the noncirrhosis subcohort. (B) Cumulative incidence of HCC in the noncirrhosis subcohort. (C) Cumulative incidence of death or transplantation in the cirrhosis subcohort. (D) Cumulative incidence of HCC in the cirrhosis subcohort. Gastroenterology 2014 147, 152-161DOI: (10.1053/j.gastro.2014.02.033) Copyright © 2014 AGA Institute Terms and Conditions